Radhakrishnan Jai, Remuzzi Giuseppe, Saran Rajiv, Williams Desmond E, Rios-Burrows Nilka, Powe Neil, Brück Katharina, Wanner Christoph, Stel Vianda S, Venuthurupalli Sree K, Hoy Wendy E, Healy Helen G, Salisbury Anne, Fassett Robert G, O'Donoghue Donal, Roderick Paul, Matsuo Seiichi, Hishida Akira, Imai Enyu, Iimuro Satoshi
Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Azienda Ospedaliera Papa Giovanni XXIII, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.
Kidney Int. 2014 Aug;86(2):246-50. doi: 10.1038/ki.2014.190. Epub 2014 Jun 4.
Chronic kidney disease is now recognized to be a worldwide problem associated with significant morbidity and mortality and there is a steep increase in the number of patients reaching end-stage renal disease. In many parts of the world, the disease affects younger people without diabetes or hypertension. The costs to family and society can be enormous. Early recognition of CKD may help prevent disease progression and the subsequent decline in health and longevity. Surveillance programs for early CKD detection are beginning to be implemented in a few countries. In this article, we will focus on the challenges and successes of these programs with the hope that their eventual and widespread use will reduce the complications, deaths, disabilities, and economic burdens associated with CKD worldwide.
慢性肾脏病现已被公认为是一个全球性问题，与严重的发病率和死亡率相关，且进入终末期肾病的患者数量急剧增加。在世界许多地区，该疾病影响着没有糖尿病或高血压的年轻人。其对家庭和社会造成的成本可能巨大。早期识别慢性肾脏病可能有助于预防疾病进展以及随后的健康和寿命下降。一些国家已开始实施早期慢性肾脏病检测的监测项目。在本文中，我们将聚焦于这些项目面临的挑战和取得的成功，希望它们最终能得到广泛应用，从而减少全球范围内与慢性肾脏病相关的并发症、死亡、残疾和经济负担。
